Research Article
Exploring the Mechanism of Berberine Intervention in Ulcerative Colitis from the Perspective of Inflammation and Immunity Based on Systemic Pharmacology
Figure 2
(a) The body weight. (b) Effect of berberine on CMDI. (c) Pathological changes of colon (compared with normal control group, < 0.05 and < 0.01; compared with model group, < 0.0 and < 0.01; H&E staining, x100; A, normal group; B, model group; and C, berberine group).
(a) |
(b) |
(c) |